national stem-cell therapy logo

Coeptis Therapeutics Advances with Groundbreaking Stem Cell Therapy in Phase 2 Program

Coeptis Therapeutics

In a significant stride towards revolutionizing the treatment of viral infections, Coeptis Therapeutics, Inc., a name synonymous with innovation in the biopharmaceutical realm, has announced its plans to embark on a Phase 2 program. This program is centered around its proprietary, first-in-class allogeneic NK cell therapy, showcasing a pivotal moment in the pursuit of advanced […]